Kenan İzgi

520 citations
23 papers · 423 indexed · h-index 14

Impact in

  • Toxicology top 5%
    • Bioactive Compounds and Antitumor Agents
  • Urology top 5%
    • Urinary Bladder and Prostate Research
    • Urological Disorders and Treatments

Papers in

    • Bioactive Compounds and Antitumor Agents 4
    • Urinary Bladder and Prostate Research 6

Kenan İzgi

22 papers receiving 418 citations

Peers

Kenan İzgi
Comparison fields: 5 of 82
  • Toxicology 63
  • Urology 111
  • Complementary and alternative medicine 91
  • Rheumatology 54
  • Dermatology 31
Replace Çağrı Şakalar with:
Çağrı Şakalar Türkiye
Hani A. Al‐Shobaili Saudi Arabia
Xiucheng Li China
F C Jolicoeur Canada
Dingsheng Lin China
Barbara Zegarska Poland
Yanling Hu China
Ahmed R. Abu‐Raghif Iraq
Francesca Satolli Italy
Kenan İzgi relative to Çağrı Şakalar Türkiye Çağrı Şakalar's profile →
Citations per field
00.5×1.5×
Çağrı Şakalar · 1×
Citations per year

Countries citing papers authored by Kenan İzgi

Since Specialization
Citations

This map shows the geographic impact of Kenan İzgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenan İzgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenan İzgi more than expected).

Fields of papers citing papers by Kenan İzgi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenan İzgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenan İzgi. The network helps show where Kenan İzgi may publish in the future.

Co-authors

The 24 scholars most cited alongside Kenan İzgi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenan İzgi Line = papers co-authored together Kenan İzgi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20175
2 20176
3 201613
4 201633
5 201619
6 20164
7 20157
8 201514
9 201531
10 201516
11 201518
12 201524
13 20153
14 201558
15 201529
16 201419
17 201434
18
Kanser immün terapi ve monoklonal antikorlar
20134
19 201331
20 201320

About Kenan İzgi

Kenan İzgi is a scholar working on Toxicology, Urology, Complementary and alternative medicine, Dermatology and Immunology and Allergy, having authored 23 papers that have together received 423 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (6 papers), Bioactive Compounds and Antitumor Agents (4 papers), Dermatology and Skin Diseases (3 papers), Urticaria and Related Conditions (3 papers), Nigella sativa pharmacological applications (3 papers), Cancer Cells and Metastasis (3 papers), Urinary Tract Infections Management (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Toxicology (63 citations), Urology (111 citations), Complementary and alternative medicine (91 citations), Rheumatology (54 citations) and Dermatology (31 citations). Kenan İzgi has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Halit Canatan, Banu İskender, Çağrı Şakalar, Firouz Daneshgari, Cengiz Z. Altuntas, Ahmet Özer, Vincent K. Tuohy, Johann Jauch, Scott J. Hultgren and Guiming Liu. Their work appears in journals such as Tumor Biology, American Journal of Physiology-Renal Physiology, Pathogens and Disease, European Cytokine Network and Journal of Biochemical and Molecular Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026